EcoDrugPlus

Transcription Factor P65-Like

Ensembl ID : ENSKMAG00000003774
Gene Symbol: LOC108239405
3 Cross references
199 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSKMAG00000007088
Gene Symbol: TRPA1
3 Cross references
200 Possible Orthologues:

Tryptophan 5-Hydroxylase 1-Like

Ensembl ID : ENSKMAG00000013199
Gene Symbol: LOC108237877
3 Cross references
176 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSKMAG00000021337
Gene Symbol: TPH1
3 Cross references
207 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSKMAG00000009591
Gene Symbol: TUBA4A
3 Cross references
170 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSKMAG00000020741
Gene Symbol: TUBA4A
4 Cross references
156 Possible Orthologues:

Tubulin Alpha-1b Chain-Like

Ensembl ID : ENSKMAG00000019320
Gene Symbol: LOC108236391
2 Cross references
39 Possible Orthologues:

Tubulin Alpha-1b Chain-Like

Ensembl ID : ENSKMAG00000006479
Gene Symbol: LOC108251018
2 Cross references
95 Possible Orthologues:

Tubulin Beta 4b Class Ivb

Ensembl ID : ENSKMAG00000008714
Gene Symbol: TUBB4B
4 Cross references
21 Possible Orthologues:

Tubulin Beta Chain-Like

Ensembl ID : ENSKMAG00000021605
Gene Symbol: LOC108242657
2 Cross references
89 Possible Orthologues:

Tubulin Beta-2a Chain-Like

Ensembl ID : ENSKMAG00000014113
Gene Symbol: LOC108239677
2 Cross references
252 Possible Orthologues:

Tubulin Beta-6 Chain

Ensembl ID : ENSKMAG00000013126
Gene Symbol: LOC108231715
2 Cross references
184 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).